Lingua: Inglese
Editore: VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG, 2014
ISBN 10: 3659515825 ISBN 13: 9783659515828
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. pp. 52.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2014
ISBN 10: 3659515825 ISBN 13: 9783659515828
Da: preigu, Osnabrück, Germania
EUR 33,20
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. The effects of erythropoietin on telomerase in malignant cells | Orit Uziel (u. a.) | Taschenbuch | 52 S. | Englisch | 2014 | LAP LAMBERT Academic Publishing | EAN 9783659515828 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing Jul 2014, 2014
ISBN 10: 3659515825 ISBN 13: 9783659515828
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 35,90
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The study described in this book presents the effects of erythropoietin on Telomerase activity and regulation in malignant and non- malignant non-erythroid cells. Erythropoietin's exposure upregulates telomerase activity in a post translational level by the Lyn/SRC AKT axis. Inhibition of telomerase that shortens telomeres abolished that effect, suggesting that erythropoietin's treatment might be given with anti- telomerase compounds to minimize the upregulation of telomerase in the cancer cells. 52 pp. Englisch.
Lingua: Inglese
Editore: VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG, 2014
ISBN 10: 3659515825 ISBN 13: 9783659515828
Da: Majestic Books, Hounslow, Regno Unito
EUR 57,47
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand pp. 52 2:B&W 6 x 9 in or 229 x 152 mm Perfect Bound on Creme w/Gloss Lam.
Lingua: Inglese
Editore: VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG, 2014
ISBN 10: 3659515825 ISBN 13: 9783659515828
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 58,06
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND pp. 52.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2014
ISBN 10: 3659515825 ISBN 13: 9783659515828
Da: moluna, Greven, Germania
EUR 31,27
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Uziel OritOrit Uziel got her Ph.D degree from the Tel Aviv University, Israel at 2000. Since then she is running the Laboratory for Telomere Research together with prof. Lahav and Prof. Nordenberg at the Felsenstein Medical Research .
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing Jul 2014, 2014
ISBN 10: 3659515825 ISBN 13: 9783659515828
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 35,90
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The study described in this book presents the effects of erythropoietin on Telomerase activity and regulation in malignant and non- malignant non-erythroid cells. Erythropoietin's exposure upregulates telomerase activity in a post translational level by the Lyn/SRC AKT axis. Inhibition of telomerase that shortens telomeres abolished that effect, suggesting that erythropoietin's treatment might be given with anti- telomerase compounds to minimize the upregulation of telomerase in the cancer cells.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 52 pp. Englisch.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2014
ISBN 10: 3659515825 ISBN 13: 9783659515828
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 35,90
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The study described in this book presents the effects of erythropoietin on Telomerase activity and regulation in malignant and non- malignant non-erythroid cells. Erythropoietin's exposure upregulates telomerase activity in a post translational level by the Lyn/SRC AKT axis. Inhibition of telomerase that shortens telomeres abolished that effect, suggesting that erythropoietin's treatment might be given with anti- telomerase compounds to minimize the upregulation of telomerase in the cancer cells.